Correlation of prostate tumor eccentricity and Gleason scoring from prostatectomy and multi-parametric-magnetic resonance imaging.

Tumor morphology histology of wholemount prostatectomy multi-parametric MRI prostate cancer supervised target detection

Journal

Quantitative imaging in medicine and surgery
ISSN: 2223-4292
Titre abrégé: Quant Imaging Med Surg
Pays: China
ID NLM: 101577942

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 12 01 2021
accepted: 22 04 2021
entrez: 4 10 2021
pubmed: 5 10 2021
medline: 5 10 2021
Statut: ppublish

Résumé

Proliferating cancer cells interacting with their microenvironment affects a tumor's spatial shape. Elongation or roundness (eccentricity) of lung, skin, and breast cancers indicates the cancer's relative aggressiveness. Non-invasive determination of the prostate tumor's shape should provide meaningful input for prognostication and clinical management. There are currently few studies of prostate tumor shape, therefore this study examines the relationship between a prostate tumor's eccentricity, derived from spatially registered multi-parametric MRI and histology slides, and Gleason scores. A total of 26 consecutive patients were enrolled in the study. Median patient age was 60 years (range, 49 to 75 years), median PSA was 5.8 ng/mL (range, 2.3 to 23.7 ng/mL, and median Gleason score was 7 (range, 6 to 9). Multi-parametric MRI (T1, T2, Diffusion, Dynamic Contrast Enhanced) were resampled, rescaled, translated, and stitched to form spatially registered multi-parametric cubes. Multi-parametric signatures that characterize prostate tumors were inserted into a target detection algorithm (Adaptive Cosine Estimator, ACE). Various detection thresholds were applied to discriminate tumor from normal tissue. Also, tumor shape was computed from the histology slides. Blobbing, labeling, and calculation of eccentricity using moments of inertia were applied to the multi-parametric MRI and histology slides. The eccentricity measurements were compared to the Gleason scores from 25 patients. From histology slides analysis: the correlation coefficient between the eccentricity for the largest blob and a weighted average eccentricity against the Gleason score ranged from -0.67 to -0.78 for all 18 patients whose tumor volume exceeded 1.0 cc. From multi-parametric MRI analysis: the correlation coefficient between the eccentricity for the largest blob for varying thresholds against the Gleason score ranged from -0.60 to -0.66 for all 25 patients showing contrast uptake in the Dynamic Contrast Enhancement (DCE) MRI. Spherical shape prostate adenocarcinoma shows a propensity for higher Gleason score. This novel finding follows lung and breast adenocarcinomas but depart from other primary tumor types. Analysis of multi-parametric MRI can non-invasively determine the prostate tumor's morphology and add critical information for prognostication and disease management. Eccentricity of smaller tumors (<1.0 cc) from MP-MRI correlates well with Gleason score, unlike eccentricity measured using histology of wholemount prostatectomy.

Sections du résumé

BACKGROUND BACKGROUND
Proliferating cancer cells interacting with their microenvironment affects a tumor's spatial shape. Elongation or roundness (eccentricity) of lung, skin, and breast cancers indicates the cancer's relative aggressiveness. Non-invasive determination of the prostate tumor's shape should provide meaningful input for prognostication and clinical management. There are currently few studies of prostate tumor shape, therefore this study examines the relationship between a prostate tumor's eccentricity, derived from spatially registered multi-parametric MRI and histology slides, and Gleason scores.
METHODS METHODS
A total of 26 consecutive patients were enrolled in the study. Median patient age was 60 years (range, 49 to 75 years), median PSA was 5.8 ng/mL (range, 2.3 to 23.7 ng/mL, and median Gleason score was 7 (range, 6 to 9). Multi-parametric MRI (T1, T2, Diffusion, Dynamic Contrast Enhanced) were resampled, rescaled, translated, and stitched to form spatially registered multi-parametric cubes. Multi-parametric signatures that characterize prostate tumors were inserted into a target detection algorithm (Adaptive Cosine Estimator, ACE). Various detection thresholds were applied to discriminate tumor from normal tissue. Also, tumor shape was computed from the histology slides. Blobbing, labeling, and calculation of eccentricity using moments of inertia were applied to the multi-parametric MRI and histology slides. The eccentricity measurements were compared to the Gleason scores from 25 patients.
RESULTS RESULTS
From histology slides analysis: the correlation coefficient between the eccentricity for the largest blob and a weighted average eccentricity against the Gleason score ranged from -0.67 to -0.78 for all 18 patients whose tumor volume exceeded 1.0 cc. From multi-parametric MRI analysis: the correlation coefficient between the eccentricity for the largest blob for varying thresholds against the Gleason score ranged from -0.60 to -0.66 for all 25 patients showing contrast uptake in the Dynamic Contrast Enhancement (DCE) MRI.
CONCLUSIONS CONCLUSIONS
Spherical shape prostate adenocarcinoma shows a propensity for higher Gleason score. This novel finding follows lung and breast adenocarcinomas but depart from other primary tumor types. Analysis of multi-parametric MRI can non-invasively determine the prostate tumor's morphology and add critical information for prognostication and disease management. Eccentricity of smaller tumors (<1.0 cc) from MP-MRI correlates well with Gleason score, unlike eccentricity measured using histology of wholemount prostatectomy.

Identifiants

pubmed: 34603979
doi: 10.21037/qims-21-24
pii: qims-11-10-4235
pmc: PMC8408776
doi:

Types de publication

Journal Article

Langues

eng

Pagination

4235-4244

Informations de copyright

2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/qims-21-24). Dr. PC reports that he has US government patents that generate some royalties that are distantly related to content (Fusion biopsy system for prostate MRI and AI systems for prostate MRI). However, these are not in conflict with the content of this article. The other authors have no conflicts of interest to declare.

Références

Cell. 2006 Dec 1;127(5):905-15
pubmed: 17129778
PLoS One. 2015 Dec 15;10(12):e0143811
pubmed: 26669540
J Urol. 2008 Nov;180(5):1964-7; discussion 1967-8
pubmed: 18801515
J Urol. 1990 Jun;143(6):1183-7
pubmed: 2342179
J Urol. 2011 Nov;186(5):1818-24
pubmed: 21944089
Cell Commun Signal. 2011 Sep 13;9:18
pubmed: 21914164
Cancer Res. 2009 May 15;69(10):4493-501
pubmed: 19366801
Thorac Cancer. 2020 Sep;11(9):2600-2609
pubmed: 32705793
Front Oncol. 2013 Apr 16;3:87
pubmed: 23596570
Int J Cancer. 2000 Dec 20;90(6):326-30
pubmed: 11180135
J Clin Aesthet Dermatol. 2015 Feb;8(2):15
pubmed: 25741397
J Digit Imaging. 2013 Dec;26(6):1045-57
pubmed: 23884657
Radiology. 2010 Apr;255(1):89-99
pubmed: 20308447
Hum Pathol. 1992 Mar;23(3):258-66
pubmed: 1555836
Eur Urol. 2012 May;61(5):1019-24
pubmed: 22336380
Interact Cardiovasc Thorac Surg. 2012 Jul;15(1):73-6
pubmed: 22514255
Rev Sci Instrum. 2009 Oct;80(10):104301
pubmed: 19895076
Cell Commun Signal. 2020 Apr 7;18(1):59
pubmed: 32264958
Acta Radiol. 2015 Mar;56(3):269-75
pubmed: 24558165
Quant Imaging Med Surg. 2021 Jan;11(1):119-132
pubmed: 33392016
J Magn Reson Imaging. 1999 Sep;10(3):223-32
pubmed: 10508281
Eur Urol. 2016 Jan;69(1):16-40
pubmed: 26427566
Comput Biol Med. 2018 Mar 1;94:65-73
pubmed: 29407999

Auteurs

Rulon Mayer (R)

University of Pennsylvania, Philadelphia, PA, USA.
OncoScore, Garrett Park, MD, USA.

Charles B Simone (CB)

New York Proton Center, New York, NY, USA.

Baris Turkbey (B)

National Institutes of Health, Bethesda, MD, USA.

Peter Choyke (P)

National Institutes of Health, Bethesda, MD, USA.

Classifications MeSH